Abstract The study assessed the pattern of diabetes care in India. Data on investigations, drug prescription, review visits and education methods were obtained from different health centers. HbA 1c tests and self monitoring practices were inadequate. Basic investigations and drug prescriptions were compromised. Screening for complications was not regularly done. The patients preferred treatment from private to public health sector. There is non adherence of established guidelines for diabetes care. There is a wide gap between translation of research findings and recommendations and their implementation during practice at all levels of health care in India.
Introduction
According to Diabetes Atlas -fourth edition, published by International Diabetes Federation (IDF), India alone will have 50.8 million people with diabetes in 2010. India is a fast growing economy, and has diverse population, with varying levels of literacy, income, traditional and cultural beliefs and varieties of diet pattern. With the current epidemiological transition, the disease pattern shows evidence of shift from communicable to non-communicable diseases, which is more significant in the urban areas [1] . The prevalence of diabetes is high in urbanized society, and the reported prevalence of diabetes in rural India varies from 3.6% to 12.5% [2] . Thus, a profound burden is placed on the healthcare system to manage diabetes mellitus and its complications. The health-care sector is mostly privatized in India, and most people prefer the private to public health sector [3] .
At the onset, it is essential to determine the practices adopted during diabetes care at all levels, both on the part of the government and in the private sector. We hypothesize that the recommended guidelines for diabetes service delivery are not standardized and are not being implemented uniformly at all levels of healthcare in a country that has the highest number of people with diabetes, namely India. Very little research has been conducted in India to study the quality of diabetes care and management across different health settings [4] . Hence, it is necessary to study and determine the pattern of diabetes service delivery in this country, the main aim of this study. This paper determines the healthcare delivery of diabetes in terms of patients' profiles, investigations, patterns of prescription of drugs and economics of diabetes care under three different settings. The paper may serve as an evidence-based document to highlight the need for improved diabetes care and to implement the standard of care at all levels that the patient deserves.
Methods
The study used a cross sectional design (house to house survey) with a multistage cluster random sampling technique from the zones which were selected based on the directions -north, south, east and west, to obtain a representative sample. With the prevalence of diabetes as 19%, 80% power, .05 level of significance and a precision of six, the sample size required was 168. Patients with diabetes who had taken treatment for diabetes from any health center, and those who had maintained hospital records, were considered for further data collection. Data were collected using a questionnaire developed by epidemiologists, which was pilot tested, with suitable modifications being incorporated. The questionnaire was administered by trained research officers in the field of diabetes epidemiology, with each interview lasting for approximately 45 min. The questionnaire incorporated, section by section, details regarding sociodemographic characteristics, place of diabetes care, the investigation details, types of drugs prescribed and taken, any history of diabetes complications, counseling methods and cost patterns. The entire data were then categorized into three groups, as described above, and the statistics were computed and compared for the parameters under study, using SPSS version 10.0. Percentages have been reported for the categorical variables, and student t-test, z-test and median tests were conducted to obtain statistical differences wherever applicable.
Results
The study population comprised 180 patients, who responded well to the interview. The distribution of patients attending the health centers was as follows; Group I: Diabetes Specialty Centres -83 patients, Group II: Private Clinics -82 patients, and Group III: those visiting Government Hospitals -15 patients. The patient characteristics and the socio-demographic profile are described in Table 1 , for the three groups with the denominator taken as per the size of the listed variable. The age and gender distribution of the study sample were similar in Group I and II. Most patients seeking treatment from the government centers belonged to the first income tertile, while there were none from the highest income group visiting the government centers. Increase in income was directly proportional to the increase in the number of patients visiting diabetes specialty centers, while it was inversely proportional to private clinics. Those patients who had attained higher education and those in white collar jobs preferred private treatment.
As the chronic nature of the disease increased, patients opted to seek treatment from specialized centers. The distribution of patients with less than 5 years duration of diabetes was as follows; Group I -31%, Group II -56.3% and Group III -12.7%. An increase in the duration of diabetes showed a significant increase and shift toward specialty centers: for instance, for greater than 10 years duration, the figures were 60.3%, 34.9%, and 4.8% for Group I, II, and III, respectively.
The HbA 1 c test was not prescribed at the government centers, while only 31.7% and 6.1% of Group I and II had it checked. Among them, Group I patients seem to have a better control of diabetes, compared to Group II (p = 0.031), as their mean HbA1c was comparatively lower. Other investigations, such as retinal examinations, foot examinations and cardiac checkups were conducted only among 28% and 21.7% of Group I and II patients, while the investigations were never prescribed during routine visits in government centres. The estimation of blood through fasting and post prandial method was the only test prescribed at government centres. The practice of self monitoring of glucose (SMBG) was observed among 26.8% and 10.8% of the Group I and II patients, respectively. Professional advice and counseling regarding healthy lifestyle-like diet modification and physical activity methods was given only at specialized diabetes centers. Group II and III patients had never been counseled, or advised on lifestyle modification during routine visits (Table 2) .
Around 59% of the study sample had developed at least one complication related to diabetes. Table 3 shows the distribution of patients according to the complication. Diabetes patients who develop complications preferred treatment at a diabetes specialty center, but the differences across the groups did not reach statistically significance levels.
The pattern of drug prescription varied across the three groups described in Table 4 . Sulphonylureas and/or biguanides were the basic drug in all prescriptions across the overall sample. In addition to this, compounds like thiazolidinediones and a-glucosidase inhibitors and DPP4 inhibitors were prescribed in Group I and II patients. Around 16% of the patients used insulin, of whom 13.5% were from Group I and 2.7% from Group II. Surprisingly none of the patients attending government centers were on insulin. Similarly cardio protective medication, such as statins and anticoagulants were commonly used at specialized centers (17.6%) and its use declined to 4.1%, at private clinics and to 1% at government centers.
The socioeconomics related to diabetes care in the community is illustrated in Table 5 in terms of direct, indirect and intangible costs. The per annum direct cost, which includes consultation fees, investigations and medication cost, was significantly higher for Group I -16,200 INR than Group II -9450 INR. Indirect cost which calculated the loss in income was also higher for Group I, but never reached statistical significance. The bidding method to determine intangible costs was based on how much money the patients were willing to spend every month to prevent future problems, was again significantly higher in Group I.
Discussion
The challenge in diabetes care and management in India is set to become still tougher, due to rising prevalence rates of diabetes. The health care system in India broadly consists of two categories -governmental and private. The private health sector is clustered around urban areas, and consists of all types of private hospitals and family clinics. The government system operates through medical institutions and tertiary care centers in urban areas and as primary health centers and district hospitals which largely dominate in rural areas.
This study has important findings from two points of viewthe treatment seeking behavior of diabetes patients in the community and the type of diabetes care delivery at various health care systems. We found that only 8% of the study population visited government hospitals, which was in agreement with the findings from other reports and studies [5] . The low income group, those with lesser duration of diabetes and those with The percentages have been derived across the row or for the listed variable on the whole whichever is applicable. nil complications are the type of patients who sought diabetes care from small private clinics and government set up. It was also observed that with a gradual increase in the duration of diabetes, and with the development of complications, patients preferred to seek treatment from specialized diabetes centers. These results serve as initial evidence for the sub-standard care offered at various levels.
Evidence from the research suggests that maintaining optimum glycemic levels may delay the onset of complications and prevent premature mortality [6] . ADA and EASD have brought out consensus and guidelines to achieve the goals in diabetes management [7] . With the effective implementation of these guidelines in various programmes, they succeeded in lowering both morbidity and mortality rates. Pertaining to the needs of our country, the excerpts from them were reframed and published in 2002, with a strong focus on comprehensive diabetes care [8] . ICMR guidelines for management of type 2 diabetes, framed in 2005, emphasize the same [9] . The IDF Clinical Guidelines Task Force has established global guidelines for type 2 diabetes, based on the availability and affordability of resources in the countries, broadly under three levels of care -standard care, comprehensive care and minimal care [10] . Our results document some of the important drawbacks in terms of the quality of diabetes care, from the point of view of clinical monitoring, self monitoring, screening for complications, education, lifestyle management, etc, indicating a direct deviation from these guidelines. For instance, adherence to HbA 1 c testing was nil in government centers and negligible in private clinics. Even among specialized diabetes centers, only 31% recommended HbA1c tests, where similar results were shown in other studies [11] . When A 1 c assay is recommended and considered as a diagnostic test for type 2 diabetes, besides clinical monitoring, our study on the other hand has reported the underutilization of A1c tests, even during routine visits. With the availability of many national and international guidelines, the study observed a gross deviation in its implementation during clinical practice.
Another issue of concern is the inappropriate screening for other complications during routine visits. Despite claims of regular screening for retinal, renal, cardiac and foot complications, this screening was seen as less than adequate even among specialized centers and private clinics and was never practiced at government centers. The late detection of complications imposes an enormous burden on the patients in terms of economics, psychosocial issues, morbidity and even early mortality. If cost and resources are deficient, simple cost effective proce- dures may be adopted to screen for individual complications, such as detecting microalbuminuria for nephropathy, monofilament test for peripheral neuropathy, etc, as per IDF guidelines, for minimal care. Self monitoring of blood glucose leads to better glycemic control and delay in development of complications [12] , but it was important to note that in this study, it was neither advised nor practiced among the patients attending the government centers, while even the specialty centers showed poor prevalence of practices of self monitoring of blood glucose. These results are similar to the DiabCare Asia -India study, which has also found a low frequency of self monitoring [13] . The effective management of diabetes is a combination of medication and lifestyle change. A further important finding was the absence of educative and interactive sessions on diabetes management during the review visits. Education on lifestyle modification and patient counseling was never conducted except in some specialty centers. These results showed a total lack of patient education during diabetes service delivery, which is considered vital in terms of effective glycemic control and good long term health devoid of complications. These findings provide additional evidence for substandard practices and lack of comprehensive diabetes care.
The specialized centers generally gave more comprehensive prescriptions, featuring insulin or OHAs, along with cardio protective drugs. The government health centers, on a routine basis, prescribed only biguanides and sulphonylureas irrespective of the level of glycemic control and the duration of diabetes. Even though insulin was available free of charge, none of our study patients from government centers were on insulin, probably due to two primary reasons identified during interview process -lack of availability of insulin and the lack of trained staff to teach about the methods of injection practices and poor facilities for storage and maintenance (data not shown). These findings are supported by evidence from other published reports from the WHO [14] and a rural study [15] . In addition to this, in the absence of national reforms and insurance policies, the problem seems to be further exacerbated, as evidence shows the increased cost of diabetes management and poor affordability of patients in meeting their expenses, thereby indirectly affecting metabolic control, as discussed elsewhere [16] .
The public health system in India is successful in preventing and managing certain communicable diseases, such as leprosy, HIV-AIDS and in resourcing programmes, such as the immunization and maternal child health programmes [17] . However, the allocation of programmes for non communicable diseases is limited. With the launch of National Rural Health Mission in 2005, and the programmes for prevention and control of diabetes, cardiovascular diseases and stroke, there has been a highly commendable focus on non communicable diseases. In this case, our study might serve to identify the deficiencies in diabetes service delivery, so that planning solutions and working out strategies may be undertaken and such programmes may be implemented more effectively.
To conclude, the study reports a wide gap that exists between the recommended clinical guidelines for diabetes care and the actual diabetes service delivery. Non adherence to the recommended guidelines may lead to poorer glycemic control, with the direct effect of increasing the complications and deepening the cost burden. These results are a reminder of the grave dangers in the future arising from the growing prevalence of diabetes, and they highlight the urgent need to address the issues.
Clinical monitoring and screening for complications are essential inasmuch as screening for diabetes and health promotion activities serve to reduce the burden of diabetes in this country. In addressing issues relating to diabetes prevention, diabetes care and meeting the cost must be made into a national health priority. Framing strategies, reorganizing health care structure and standardizing procedures to better implement the global guidelines for type 2 diabetes are of utmost importance. The effectiveness and sustainability of diabetes service delivery at the government level and among the private practitioners should be an overall aim, since most of the population is largely dependent on them.
